BELBIC stands for "BElimumab for the treatment of systemic lupus erythematosus." It refers to a specific medication (Belimumab) used in the treatment of systemic lupus erythematosus (SLE), which is an autoimmune disease. Belimumab works by inhibiting the activity of B-lymphocyte stimulator (BLyS), a protein that plays a role in the survival of B cells, which are involved in the autoimmune response.
Articles by others on the same topic
There are currently no matching articles.